Association of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis

Korean Journal of Internal Medicine

Volumn 21, Issue 1, 2006, Pages 33-38

  Lee, Jung Ahn ^a   Kim, Do Hyung ^a   Yu, Soo Jeong ^a   Oh, Dong Jin ^a   Yu, Suk Hee ^a  

^a Chung Ang University   (South Korea)

Author keywords

CAPD; CAVI (cardio ankle vascular index)

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOMOCYSTEINE; HUMAN SERUM ALBUMIN; LIPID; PHOSPHORUS; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ANALYTIC METHOD; ANKLE; ARTERIOSCLEROSIS; ARTICLE; BODY FAT; CALCIUM BLOOD LEVEL; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEART VALVE; HUMAN; HYPERTENSION; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MALE; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PULSE WAVE; REGRESSION ANALYSIS;

EID: 33646694966     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2006.21.1.33     Document Type: Article

References (30)

1. Lang RM, Fellner SK, Neumann A, Bushinsky DA, Borow KM. Left ventricular contractility varies directly with blood ionized calcium. Ann Intern Med 108:524-529, 1988
2. Fang J, Madganan S, Cohen H, Alderman MH. Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens 13:413-419, 1995
3. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439, 1999
4. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave refections and survival in end-stage renal failure. Hypertension 38:434-438, 2001
5. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 16:85-94, 2003
6. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97:138-141, 1998
7. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61:609-614, 2002
8. van Guldner C, Lambert J, ter Wee PM, Donker AJ, Stehouwer CD. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. Clin Nephrol 53:33-41, 2000
9. Smilde TJ, van den Berkmortel FW, Boers GH, Wollersheim H, de Boo T, van Langen H, Stalenhoef AF. Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 18:1958-1963, 1998
10. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18:535-541, 1998
11. Oh DJ, Lee KJ. The relation between hypoalbuminemia and compliance and intima-media thickness of carotid artery in continuous ambulatory peritoneal dialysis patients. J Korean Med Sci 20:70-74, 2005
12. Axelsson J, Rashid Qureshi A, Suliman ME, Honda H, Pecoits-Filho R, Heimburger O, Lindholm B, Cederholm T, Stenvinkel P. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80:1222-1229, 2004
13. Schimmler W, Hooffacker M. Spontaneous changes in blood pressure and aortic pulse wave velocity in normotensive subjects (results of a long-term study in 183 men). Basic Res Cardiol 70:521-530, 1975
14. Bercu BB, Haupt R, Johnsonbaugh R, Rodbard D. The pulse wave arrival time (QKd interval) in normal children. J Pediatr 95:716-721, 1979
15. Yambe T, Yoshizawa M, Saijo Y, Yamaguchi T, Shibata M, Konno S, Nitta S, Kuwayama T. Brachio-ankle pulse wave velocity and cardio-ankle vascular index. Biomed Pharmacother 58(Suppl):S95-S98, 2004
16. Wakabayashi I, Masuda H. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 365:230-235, 2006
17. Beddhu S, Kaysen GA, Yan G, Samak M, Agodoa L, Ornt D, Cheung AK. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 40:721-727, 2002
18. Cooper BA, Penne EL, Barlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 43:61-66, 2004
19. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity and ortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1956
20. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987
21. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057-1058, 1987
22. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology and potential relationship to arteriosclerotic outcome. Kidney Int 52:10-20, 1997
23. Suliman ME, Stenvinkel P, Barany P, Heimburger O, Anderstam B, Lindholm B. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 41(3 Suppl 1): S89-S95, 2003
24. Arcaro G, Fava C, Dagradi R, Faccini G, Gaino S, Degan M, Lechi C, Lechi A, Minuz P. Acute hyperhomocysteinemia induces a reduction in arterial distensibility and compliance. J Hypertens 22:775-781, 2004
25. Sydow K, Hornig B, Arakawa N, Bode-Boger SM, Tsikas D, Munzel T, Boger RH. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. Vasc Med 9:93-101, 2004
26. Vychytil A, Fodinger M, Papagiannopoulos M, Wolfl G, Horl WH, Sunder-Plassmann G. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients. Kidney Int 55:2054-2061, 1999
27. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144:2195-2200, 2003
28. Suliman M, Axelsson J, Heimburger O, Quershi AR, barany P, Pecoits-Filho R. Relationship between circulating levels of interleukin-6 and fat mass in patients with end-stage renal disease [Abstract]. J Am Soc Nephrol 14:530A, 2003
29. Nordfors L, Heimburger O, Lonnqvist F, Lindholm B, Helmrich J, Schalling M, Stenvinkel P. Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int 57:1713-1719, 2000
30. Stompor T, Rajzer M, Sulowicz W, Dembinska-Kiec A, Janda K, Kawecka-Jaszcz K, Wojcik K, Tabor B, Zdzienicka A, Janusz-Grzybowska E. An association between aortic pulse wave velocity, blood pressure and chronic inflammation in ESRD patients on peritoneal dialysis. Int J Artif Organs 26:188-195, 2003